MetLife Investment Management, LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1529735
Whippany, NJ
Position in BMY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$29,934,717
+$2,589,241 QoQ
Shares Held
493,565
-2.6% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $714,031,909 across 12 Drug Manufacturers - General names. BMY ranks #8 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
221,464 | $203,695,943 | |
| 2 | JNJ |
Johnson & Johnson
|
563,045 | $137,630,719 | |
| 3 | ABBV |
AbbVie Inc.
|
493,002 | $107,223,004 | |
| 4 | MRK |
Merck & Co., Inc.
|
580,004 | $69,768,681 | |
| 5 | AMGN |
Amgen Inc
|
143,722 | $50,568,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
305,106 | $42,522,623 | |
| 7 | PFE |
Pfizer Inc
|
1,328,456 | $37,303,044 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
493,565 | $29,934,717 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,934,717 | 493,565 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $27,345,476 | 506,961 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $23,615,983 | 523,636 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $24,831,946 | 536,443 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $32,145,877 | 527,068 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $30,363,274 | 536,833 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,277,431 | 527,202 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $22,456,101 | 540,720 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $25,838,913 | 476,469 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $25,346,575 | 493,989 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $30,006,854 | 517,003 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $34,102,680 | 533,271 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $38,036,981 | 548,795 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $39,958,943 | 555,371 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $40,285,494 | 566,683 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $44,167,046 | 573,598 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $43,316,064 | 593,127 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $30,577,250 | 490,413 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $32,328,890 | 546,373 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $34,607,815 | 517,926 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $35,553,111 | 563,173 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $34,041,691 | 548,794 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $34,453,986 | 571,471 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $34,796,487 | 591,777 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $33,680,560 | 604,244 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||